Physician profile
Andrew Mg Davy
NPI 1891757274
$3,222.37
in general payments reported to CMS, 2019-2025
16 companies · $18.69 in 2025
The $18.69 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $201 · 2021: $1,476 · 2022: $406 · 2023: $361 · 2024: $256 · 2025: $18.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $1,273.62 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $590.64 | 2020-2023 | Relistor |
| Forte Bio-Pharma LLC | $321.45 | 2023-2024 | Prolate, Nalocet |
| Medtronic USA, INC. | $205.05 | 2019 | |
| Hikma Pharmaceuticals USA | $199.23 | 2021-2023 | Kloxxado |
| Boston Scientific Corporation | $181.20 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $150.00 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $60.87 | 2019 | |
| Biodelivery Sciences International, INC. | $48.43 | 2020-2021 | |
| Valinor Pharma, LLC | $44.64 | 2023 | Movantik |
| Daiichi Sankyo INC. | $42.25 | 2019 | |
| Pfizer INC. | $27.81 | 2019 | |
| Scilex Pharmaceuticals INC. | $22.95 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.69 | 2021 | |
| Lilly USA, LLC | $18.69 | 2025 | Omvoh |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Davy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.